About
Kristina Burow is a Managing Director at ARCH Venture Partners, where she focuses on building biotechnology, pharmaceutical, and health tech companies. She joined ARCH in 2002 after roles at the Novartis BioVenture Fund and the Genomics Institute of the Novartis Research Foundation. Public company and startup board roles listed by ARCH include Neumora Therapeutics, Orbital Therapeutics, Scholar Rock, Metsera, Boundless Bio, Mirador Therapeutics, Autobahn Therapeutics, and ROME Therapeutics.
Areas of interest
biotechpharmaceuticalshealth techprecision medicineoncologyneuroscienceimmunologyRNA medicinesobesity and metabolic diseasedigital health